LI Yang-si, CEN En-ni, WANG Zhen, TU Hai-yan. The Strategy for a Lung Cancer Patient in Stage Ⅲ B Undergoing Immune Checkpoint Inhibitor Plus Chemotherapy[J]. Journal of Evidence-Based Medicine, 2023, 23(3): 189-192. DOI: 10.12019/j.issn.1671-5144.2023.03.008
|
Citation:
|
LI Yang-si, CEN En-ni, WANG Zhen, TU Hai-yan. The Strategy for a Lung Cancer Patient in Stage Ⅲ B Undergoing Immune Checkpoint Inhibitor Plus Chemotherapy[J]. Journal of Evidence-Based Medicine, 2023, 23(3): 189-192. DOI: 10.12019/j.issn.1671-5144.2023.03.008
|
LI Yang-si, CEN En-ni, WANG Zhen, TU Hai-yan. The Strategy for a Lung Cancer Patient in Stage Ⅲ B Undergoing Immune Checkpoint Inhibitor Plus Chemotherapy[J]. Journal of Evidence-Based Medicine, 2023, 23(3): 189-192. DOI: 10.12019/j.issn.1671-5144.2023.03.008
|
Citation:
|
LI Yang-si, CEN En-ni, WANG Zhen, TU Hai-yan. The Strategy for a Lung Cancer Patient in Stage Ⅲ B Undergoing Immune Checkpoint Inhibitor Plus Chemotherapy[J]. Journal of Evidence-Based Medicine, 2023, 23(3): 189-192. DOI: 10.12019/j.issn.1671-5144.2023.03.008
|
DownLoad: